Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.650
-0.110 (-6.25%)
At close: Nov 17, 2026, 4:00 PM EST
1.640
-0.010 (-0.61%)
After-hours: Nov 17, 2026, 4:18 PM EST

Silexion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2013FY 2012
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '13 Dec '12
06342--
Market Cap Growth
-95.69%86.42%-92.30%---
Enterprise Value
-0-1641--
Last Close Price
1.76460.807235.99351539.97--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2013FY 2012
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '13 Dec '12
PB Ratio
9.272.31-0.8113.94--
P/TBV Ratio
8.852.31----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2013FY 2012
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '13 Dec '12
Debt / Equity Ratio
32.050.78-1.130.06--
Net Debt / Equity Ratio
-18.61-1.52-0.83-1.47-1.13-0.98
Net Debt / EBITDA Ratio
0.060.34-0.260.950.581.68
Net Debt / FCF Ratio
0.070.37-0.390.970.991.75
Quick Ratio
0.562.170.342.093.6410.47
Current Ratio
0.942.410.642.273.8510.64
Return on Equity (ROE)
-----116.66%-
Return on Assets (ROA)
--144.28%-193.54%--62.13%-
Return on Capital Employed (ROCE)
-5232.20%-261.00%1904.70%-153.00%-195.10%-58.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2013FY 2012
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '13 Dec '12
Earnings Yield
-56354.63%-198.44%-510.65%-11.81%--
FCF Yield
-3194.11%-180.38%-261.43%-10.85%--
SEC Filings: 10-K · 10-Q